Epidoxorubicin and lonidamine in refractory or recurrent epithelial ovarian cancer
- 31 December 1994
- journal article
- clinical trial
- Published by Elsevier
- Vol. 30 (10) , 1432-1435
- https://doi.org/10.1016/0959-8049(94)00231-s
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Phase II study of lonidamine in metastatic breast cancerBritish Journal of Cancer, 1989
- Esorubicin in advanced ovarian epithelial cancerEuropean Journal of Cancer and Clinical Oncology, 1988
- A phase II trial of 4-demethoxydaunorubicin in refractory epithelial ovarian cancerGynecologic Oncology, 1986
- Phase II Study of Lonidamine in Inoperable Non-Small-Cell Lung CancerOncology, 1984
- Early Observations on the Administration of Lonidamine in Cancer PatientsOncology, 1984
- Phase II Evaluation of Lonidamine in Patients with Advanced MalignancyOncology, 1984
- Single-agent adriamycin followed by combination hexamethylmelamine-cyclophosphamide for advanced ovarian carcinomaGynecologic Oncology, 1982
- Changes of Energy Metabolism in the Germ Cells and Ehrlich Ascites Tumor CellsChemotherapy, 1981
- Basic and Applied Research in the Study of Indazole Carboxylic AcidsChemotherapy, 1981
- Second trial drugs in ovarian cancerGynecologic Oncology, 1977